Chronic pain — defined as pain persisting beyond 3 months — affects an estimated 50 million Americans and is the most common reason people seek medical care. It is not simply acute pain that hasn't resolved. Chronic pain involves real, measurable changes in how the nervous system processes pain signals, how tissue maintains an inflammatory state, and how the brain responds to threat.

Research over the past two decades has identified several biological mechanisms that sustain chronic pain — including central sensitization (a state in which the nervous system becomes amplified, responding to normal stimuli as if they were threatening), persistent tissue hypoxia, ongoing neuroinflammation, and mitochondrial dysfunction in pain-processing neurons. These findings have shifted how researchers think about chronic pain — from a symptom to be managed to a biological state to be addressed.

Most current treatments — NSAIDs, opioids, nerve blocks, physical therapy — manage pain at the symptomatic level. Researchers are increasingly interested in interventions that operate on the underlying biology, particularly tissue oxygenation and neuroinflammation. HBOT addresses both directly.

One of the most important insights in pain science is that once the nervous system enters a state of central sensitization, pain can persist independently of the original tissue damage. The nervous system has essentially "learned" to be in pain, and ordinary inputs trigger a disproportionate response. This explains why many chronic pain patients show no structural cause on imaging — the problem is in the system's calibration, not necessarily the tissue.

At the same time, tissue-level factors often sustain and amplify the sensitization: chronic local hypoxia, persistent low-grade inflammation, and impaired cellular repair create an ongoing biological signal that keeps the nervous system on alert. Breaking this cycle requires addressing both the neurological and the tissue-level components simultaneously.

Hyperbaric oxygen therapy's ability to dramatically increase oxygen delivery to hypoxic tissue — while also demonstrating anti-inflammatory and neuroprotective effects — makes it a biologically plausible candidate for research in chronic pain populations. Researchers are investigating whether the combination of these effects can meaningfully reduce the biological drivers of chronic pain.